ORBIMED ADVISORS LLC – Kinnate Biopharma Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$48.32M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-5.23%
quarter
Kinnate Biopharma Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -2.66M | $11.95 | 4.04M | |
| Q2 2022 | share | 0.00% | 0 shares | 5.45M | $12.61 | 4.04M | |
| Q1 2022 | share | Increase | +5.09% | 195.7K shares | -22.65M | $11.26 | 4.04M |
| Q4 2021 | share | 0.00% | 0 shares | -20.39M | $18.16 | 3.84M | |
| Q3 2021 | share | 0.00% | 0 shares | -1.00M | $23.02 | 3.84M | |
| Q2 2021 | share | 0.00% | 0 shares | -30.32M | $23.28 | 3.84M | |
| Q1 2021 | share | 0.00% | 0 shares | -33.17M | $31.16 | 3.84M | |
| Q4 2020 | share | Increase | 0.00% | 3.84M shares | 153.07M | $39.78 | 3.84M |